AstraZeneca Pharma India Management
Management criteria checks 1/4
We currently do not have sufficient information about the CEO.
Key information
Sanjeev Panchal
Chief executive officer
₹38.7m
Total compensation
CEO salary percentage | 83.4% |
CEO tenure | 1.8yrs |
CEO ownership | n/a |
Management average tenure | 1.3yrs |
Board average tenure | less than a year |
Recent management updates
Recent updates
CEO Compensation Analysis
Date | Total Compensation | Salary | Company Earnings |
---|---|---|---|
Sep 30 2024 | n/a | n/a | ₹819m |
Jun 30 2024 | n/a | n/a | ₹959m |
Mar 31 2024 | ₹39m | ₹32m | ₹2b |
Dec 31 2023 | n/a | n/a | ₹1b |
Sep 30 2023 | n/a | n/a | ₹2b |
Jun 30 2023 | n/a | n/a | ₹1b |
Mar 31 2023 | ₹21m | ₹5m | ₹993m |
Compensation vs Market: Sanjeev's total compensation ($USD458.59K) is about average for companies of similar size in the Indian market ($USD481.65K).
Compensation vs Earnings: Sanjeev's compensation has increased by more than 20% whilst company earnings have fallen more than 20% in the past year.
CEO
Sanjeev Panchal (47 yo)
1.8yrs
Tenure
₹38,725,314
Compensation
Dr. Sanjeev Kumar Panchal serves as Country President of AstraZeneca Pharma India Limited since January 01, 2023 and serves as its Managing Director since January 01, 2023. He serves as Director of AstraZe...
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
MD, Country President & Director | 1.8yrs | ₹38.73m | no data | |
Whole-Time Director & CFO | 1.1yrs | ₹30.59m | no data | |
Legal Counsel | 7.8yrs | ₹3.73m | no data | |
Company Secretary & Compliance Officer | 2.3yrs | no data | no data | |
Vice President of Human Resources | no data | ₹12.28m | no data | |
Interim Business Unit Head of Oncology & Director of Commercial Excellence | 1.3yrs | no data | no data | |
Head of Oncology Business Unit | less than a year | no data | no data | |
Business Unit Head - Rare Disease unit | less than a year | no data | no data | |
Legal Head | no data | no data | no data |
1.3yrs
Average Tenure
Experienced Management: 506820's management team is not considered experienced ( 1.3 years average tenure), which suggests a new team.
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
MD, Country President & Director | 1.8yrs | ₹38.73m | no data | |
Whole-Time Director & CFO | less than a year | ₹30.59m | no data | |
Independent Non-Executive Director | 7.9yrs | ₹1.20m | no data | |
Additional Independent Director | less than a year | no data | no data | |
Additional Non-Executive Director | less than a year | no data | no data | |
Independent Non-Executive Chairperson of the Board | 2.9yrs | ₹1.30m | no data | |
Non-Executive Director | less than a year | no data | no data | |
Additional Non-Executive Director | no data | no data | no data |
0.9yrs
Average Tenure
58yo
Average Age
Experienced Board: 506820's board of directors are not considered experienced ( 0.9 years average tenure), which suggests a new board.